Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The drug suppresses appetite
Phase 3 trials are assessing CagriSema's efficacy in diverse populations over 4.5 years, focusing on weight loss and cardiovascular outcomes
Most people find the best results after 48 weeks of consistent use
Insurance coverage represents another major barrier to broader adoption
US$ 21.35
US$ 21.00
US$ 21.87
US$ 25.37
US$ 24.14
US$ 25.00
US$ 26.61
US$ 21.18
US$ 29.78
US$ 22.06
US$ 29.38
